Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
The growth in Q2FY23 revenue and operating EBITDA were driven by higher occupancies, improved payor mix, and increased ARR in OPD.
International patient revenues up 16% during quarter, 110% of pre-Covid average; PAT grows 29% on like-to-like basis